NCT06118710View on ClinicalTrials.gov

Evaluation of the Omission of Dexamethasone in Premedication Regimens During Paclitaxel Treatment

PHASE4RecruitingINTERVENTIONAL
Enrollment

500

Participants

Timeline

Start Date

June 25, 2024

Primary Completion Date

June 1, 2027

Study Completion Date

August 1, 2027

Conditions
Cancer
Interventions
DRUG

Dexamethasone

Dexamethasone prior to paclitaxel infusion according to local care standards.

DRUG

H1 Antihistaminics

Clemastine or Cetirizine prior to paclitaxel infusion according to local care standards

Trial Locations (1)

3015 CN

RECRUITING

Erasmus MC, Rotterdam

Sponsors
All Listed Sponsors
lead

Erasmus Medical Center

OTHER